Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of Akso Health Group from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Akso Health Group quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • Akso Health Group Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Sep 2025 was $198,310,938, a 1.2% decline year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

Akso Health Group Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $198,310,938 -$2,340,715 -1.2% 30 Sep 2025 6-K 10 Feb 2026 2026 Q2
Q1 2025 $199,151,136 +$60,726,942 +44% 31 Mar 2025 6-K 10 Feb 2026 2026 Q2
Q3 2024 $200,651,653 +$195,320,180 +3664% 30 Sep 2024 6-K 10 Feb 2026 2026 Q2
Q1 2024 $138,424,194 +$129,584,678 +1466% 31 Mar 2024 6-K 10 Feb 2026 2026 Q2
Q3 2023 $5,331,473 -$4,598,581 -46% 30 Sep 2023 6-K 28 Mar 2025 2025 Q2
Q1 2023 $8,839,516 -$3,446,066 -28% 31 Mar 2023 20-F 14 Aug 2025 2025 FY
Q3 2022 $9,930,054 -$9,622,150 -49% 30 Sep 2022 6-K 03 Jan 2024 2024 Q2
Q1 2022 $12,285,582 -$4,985,943 -29% 31 Mar 2022 20-F 14 Aug 2025 2025 FY
Q3 2021 $19,552,204 30 Sep 2021 6-K 16 Feb 2023 2023 Q2
Q1 2021 $17,271,525 -$30,829,364 -64% 31 Mar 2021 20-F 14 Jul 2023 2023 FY
Q1 2020 $48,100,889 -$78,402,269 -62% 31 Mar 2020 20-F 14 Jul 2023 2023 FY
Q1 2019 $126,503,158 -$13,729,597 -9.8% 31 Mar 2019 20-F 29 Dec 2022 2022 FY
Q1 2018 $140,232,755 +$116,728,399 +497% 31 Mar 2018 20-F 28 Jul 2021 2021 FY
Q1 2017 $23,504,356 +$9,492,399 +68% 31 Mar 2017 20-F 14 Aug 2020 2020 FY
Q1 2016 $14,011,957 +$10,657,372 +318% 31 Mar 2016 20-F 31 Jul 2019 2019 FY
Q1 2015 $3,354,585 31 Mar 2015 20-F 30 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.